Fuso Pharmaceutical Industries,Ltd.
扶桑薬品工業(株)
2026/08/11 Updated
Market Cap:
$117.6M (¥18.7B)
Stock Price:
$13.78 (¥2,191)
Exchange Rate: 1 USD = ¥158.98
Stock Price Chart
2026/08/11 Updated9.30
PER (Price Earnings Ratio)
vs Industry Avg: -0.2
0.53
PBR (Price to Book Ratio)
vs Industry Avg: -0.7
4.11%
Dividend Yield
vs Industry Avg: +1.16%
Price Trend
2026/08/11 UpdatedShort-term
5-Day MA
+2.01%
Near-term
25-Day MA
+0.77%
Mid-term
75-Day MA
+3.26%
Long-term
200-Day MA
-0.80%
Price & Trading Details
2026/08/11 UpdatedPRICE
Previous Close
¥2,165
Open
¥2,175
High
¥2,203
Low
¥2,168
Close
¥2,191
TRADING
Volume
21,300
Average Volume
22,310
Turnover
¥46,668,300
Min. Purchase
¥219,100
Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/11/12 | ¥51.63 | ¥47.20 | -8.6% |
Shareholder Composition
Updated 2026/08/0122.3%
Insider Holdings
17.1%
Institutional
60.7%
Public Float
26
Institutional Holders
Insider Holdings
22.3%
Institutional
17.1%
Public Float
60.7%
Dividend History
Updated 2026/08/09
-%
Dividend Yield
¥45
Annual Dividend
-48.3%
YoY Growth
19.1%
Payout Ratio
| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥45 | -48.3% |
| 2025 | ¥87 | +16.0% |
| 2024 | ¥75 | 0.0% |
| 2023 | ¥75 | +25.0% |
| 2022 | ¥60 | - |
Financial Performance
2026/08/09 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥51,015M | ¥55,406M | ¥60,562M | ¥62,307M |
| Gross Profit | ¥13,740M | ¥13,838M | ¥16,532M | ¥15,995M |
| Operating Income | ¥2,207M | ¥1,964M | ¥4,131M | ¥2,640M |
| Pretax Income | ¥2,370M | ¥1,938M | -¥4,809M | ¥2,766M |
| Net Income | ¥1,605M | ¥1,377M | -¥3,288M | ¥2,011M |
| EPS | ¥183.07 | ¥159.98 | -¥384.95 | ¥235.63 |
| Operating Margin | 4.33% | 3.54% | 6.82% | 4.24% |
| Balance Sheet | ||||
| Total Assets | ¥72,466M | ¥75,802M | ¥81,729M | ¥90,323M |
| Total Equity | ¥35,649M | ¥36,661M | ¥33,043M | ¥35,057M |
| Total Liabilities | ¥36,817M | ¥39,141M | ¥48,686M | ¥55,266M |
| Cash | ¥8,014M | ¥5,120M | ¥6,264M | ¥4,846M |
| Interest-bearing Debt | ¥12,632M | ¥13,711M | ¥21,289M | ¥28,462M |
| Equity Ratio | 49.19% | 48.36% | 40.43% | 38.81% |
| D/E Ratio | 0.35 | 0.37 | 0.64 | 0.81 |
| Cash Flow | ||||
| Operating CF | ¥2,853M | ¥627M | -¥3,305M | -¥6,224M |
| Investing CF | -¥1,373M | -¥3,536M | -¥3,168M | -¥1,515M |
| Financing CF | -¥813M | ¥14M | ¥7,618M | ¥6,321M |
| Free CF | ¥1,279M | -¥2,961M | -¥6,403M | -¥7,883M |
| Efficiency | ||||
| ROE | 4.50% | 3.76% | -9.95% | 5.74% |
| ROA | 2.21% | 1.82% | -4.02% | 2.23% |
Latest News (5 items)
Company Information
English Name
Fuso Pharmaceutical Industries,Ltd.
Japanese Name
扶桑薬品工業(株)
Stock Code
4538.T (JPX)
Sector / Industry
Healthcare / Drug Manufacturers - Specialty & Generic
Website
https://www.fuso-pharm.co.jp
About
Fuso Pharmaceutical Industries,Ltd. engages in the manufacture and sale of pharmaceuticals and medical equipment in Japan. The company offers injectable drugs and dialysis agents for artificial kidneys, as well as medical drugs and equipment. It also engages in the contract manufacturing of drugs; and real estate leasing businesses. The company was incorporated in 1937 and is based in Osaka, Japan.
Data provided by Yahoo Finance
